1Kiehl MG. Mycophenolate mofetil in the prevention of rejection after kidney transplantation. Transplantation, 2000, 69:1753-1754. 被引量:1
2Meier - Krieche Hid, Shaw LM, Korecka M, et al. Pharmacokinetics of mycophenolic acid in renal insufficiency. Ther Drug Monit,2000, 22:27-30. 被引量:1
3Gelder T, Hilbrands CB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation,1999, 68:261-266. 被引量:1
4Budde K, Glander P, Braun KP, et al. Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients.Transplant Proc, 2001, 33:3313-3315. 被引量:1
5Prof. G. R. Bernard MD,A. Artigas,K. L. Brigham,J. Carlet,K. Falke,L. Hudson,M. Lamy,J. R. LeGall,A. Morris,R. Spragg. Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination[J] 1994,Intensive Care Medicine(3):225~232 被引量:1